Bandingkan Harga & Kinerja Multi Hanna Kreasindo Tbk. (MHKI) vs Organon Pharma Indonesia Tbk. (SCPI)

Multi Hanna Kreasindo Tbk.Trading

Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Multi Hanna Kreasindo Tbk. dan Organon Pharma Indonesia Tbk.: Multi Hanna Kreasindo Tbk. diperdagangkan di Rp132 (kapitalisasi pasar 517,5 M, volume 24 jam 6,46 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Multi Hanna Kreasindo Tbk. jauh lebih besar — sekitar 5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

	MHKI	SCPI
Kapitalisasi Pasar	517,5 M	104,4 M
Volume	6,46 jt	—
Lot	64,61 rb	—
Perputaran	855,43 jt	—
Harga Rata-rata	132,41	—
Nilai Transaksi	855,43 jt	—
Harga Ekuilibrium Indikatif	132	—
Volume Ekuilibrium Indikatif	357	—

Lihat detail →Lihat detail →

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

MHKI

Lihat detail →

SCPI

Lihat detail →

Tentang Multi Hanna Kreasindo Tbk.

PT Multi Hanna Kreasindo Tbk (Company), was established on September 23, 2004 based on Deed of Notary Drajat Dramaji, S.H., No.165. The company became effective commercially on September 23, 2004. The parent entity of the Company is PT Multi Hanna Sinergitama and the ultimate beneficial owners of the Company are Mr. Shahabuddin and Mr. Alwi.

Selengkapnya di halaman MHKI →

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI →